CERA

Science and Research

Safety and Efficacy of NPI-001 Tablets for RP Associated with Usher Syndrome (SLO RP)

This study will examine the safety and efficacy of oral NPI-001 Tablets as compared to oral placebo tablets for 24 months in subjects with vision loss due to RP associated with Usher syndrome.

Overview

This study will examine the safety and efficacy of oral NPI-001 Tablets as compared to oral placebo tablets for 24 months in subjects with vision loss due to RP associated with Usher syndrome. The study is an interventional, randomised, double masked, treatment study and the primary outcome is to evaluate change in retinal sensitivity assessed by microperimetry from baseline, in active versus placebo subjects.
  • Principal Investigator
Dr Jonathan Ruddle

Learn more

View this study at ClinicalTrials.gov

This international database listing provides more detailed information about this study.